MedTrace Logo

GRACE - Study of AGN1 LOEP in Osteopenic and Osteoporotic Patients

NCT05966974 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2023-08-01

No results posted yet for this study

Summary

The study is designed as a retrospective, single-center study for subjects previously treated with the AGN1 LOEP Kit. This will be a non-randomized and non-blinded study. The study will collect retrospective data on the safety and performance of AGN1 LOEP of all subjects treated outside of any other clinical study protocols between September 2019 and November 2022. A prospective questionnaire will be included to evaluate self-reported subject experiences.

Conditions

Sponsors & Collaborators

  • AgNovos Healthcare, LLC

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-15
Primary Completion
2023-04-03
Completion
2023-04-03

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05966974 on ClinicalTrials.gov